scholarly article | Q13442814 |
P50 | author | Ingrid U. Scott | Q108861392 |
Darlene Miller | Q55483430 | ||
Harry W Flynn | Q89902165 | ||
P2093 | author name string | Matthew S Benz | |
Nichard Unonius | |||
P2860 | cites work | Delayed-onset bleb-associated endophthalmitis: clinical features and visual acuity outcomes | Q32101234 |
Vancomycin prophylaxis and emerging resistance: are ophthalmologists the villains? The heroes? | Q32143682 | ||
Bacterial endophthalmitis prophylaxis for cataract surgery: an evidence-based update. | Q34482240 | ||
Delayed-onset endophthalmitis associated with conjunctival filtering blebs | Q40896068 | ||
Antibiotic selection in the treatment of endophthalmitis: the significance of drug combinations and synergy | Q41481102 | ||
Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics | Q43946478 | ||
Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones | Q44328530 | ||
Vitreous and aqueous penetration of orally administered gatifloxacin in humans | Q44345029 | ||
Microbiologic spectrum and susceptibility of isolates: part I. Postoperative endophthalmitis. Endophthalmitis Research Group | Q45247469 | ||
Practice styles and preferences of ASCRS members--2000 survey. American Society of Cataract and Refractive Surgery. | Q51355338 | ||
Bactericidal effects of levofloxacin in comparison with those of ciprofloxacin and sparfloxacin. | Q54549887 | ||
The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. | Q54668829 | ||
The penetration of oral ciprofloxacin into the aqueous humor, vitreous, and subretinal fluid of humans | Q70704906 | ||
Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study | Q71136890 | ||
Microbiologic factors and visual outcome in the endophthalmitis vitrectomy study | Q71863618 | ||
Penetration of topical and oral ofloxacin into the aqueous and vitreous humor of inflamed rabbit eyes | Q73022416 | ||
Aqueous and vitreous penetration of levofloxacin after oral administration | Q73276323 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 38-42 | |
P577 | publication date | 2004-01-01 | |
P1433 | published in | American Journal of Ophthalmology | Q4744258 |
P1476 | title | Endophthalmitis isolates and antibiotic sensitivities: a 6-year review of culture-proven cases | |
P478 | volume | 137 |
Q90049914 | A Review of Antimicrobial Therapy for Infectious Uveitis of the Posterior Segment |
Q39532970 | A novel cell-associated protection assay demonstrates the ability of certain antibiotics to protect ocular surface cell lines from subsequent clinical Staphylococcus aureus challenge |
Q42720597 | A study on the incidence, microbiological analysis and investigations on the source of infection of postoperative infectious endophthalmitis in a tertiary care ophthalmic hospital: an 8-year study |
Q41725352 | Acute-onset postoperative endophthalmitis caused by multidrug-resistant Klebsiella pneumoniae |
Q46987146 | An in vitro study on the compatibility and concentrations of combinations of vancomycin, amikacin, and dexamethasone in human vitreous. |
Q35617621 | Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery |
Q40087692 | Antibiotic susceptibility profiles of ocular and nasal flora in patients undergoing cataract surgery in Taiwan: an observational and cross-sectional study |
Q50425266 | Assessment of oligogalacturonide from citrus pectin as a potential antibacterial agent against foodborne pathogens. |
Q36245439 | Bacterial Spectrum and Antibiotic Resistance Patterns of Ocular Infection: Differences between External and Intraocular Diseases |
Q36719881 | Bacterial and fungal endophthalmitis in upper Egypt: related species and risk factors |
Q36712635 | Bacterial endophthalmitis: therapeutic challenges and host-pathogen interactions |
Q27027975 | Biofilms in infections of the eye |
Q33619377 | Bleb-related Endophthalmitis: Clinical Presentation, Isolates, Treatment and Visual Outcome of Culture-proven Cases |
Q40473896 | CXCL1, but not IL-6, significantly impacts intraocular inflammation during infection. |
Q40544185 | Clinical presentations, risk factors and outcomes of ceftazidime-resistant Gram-negative endophthalmitis |
Q34255789 | Combined ceftazidime and amikacin resistance among Gram-negative isolates in acute-onset postoperative endophthalmitis: prevalence, antimicrobial susceptibilities, and visual acuity outcome |
Q36204199 | Comparison of the most common isolates of postoperative endophthalmitis in South Korea; Enterococcus species vs coagulase-negative staphylococci |
Q50354188 | Delayed fungal endophthalmitis secondary to Curvularia. |
Q41092068 | Draft Genome Sequence of Staphylococcus sciuri subsp. sciuri Strain Z8, Isolated from Human Skin |
Q34390595 | Effects of medication methods after simple and effective probing of lacrimal passage |
Q42246329 | Emergence of Enterococcus species in the infectious microorganisms cultured from patients with endophthalmitis in South Korea. |
Q37125014 | Emerging 8-methoxyfluoroquinolone resistance among methicillin-susceptible Staphylococcus epidermidis isolates recovered from patients with endophthalmitis. |
Q53746372 | Emerging Worldwide Antimicrobial Resistance, Antibiotic Stewardship and Alternative Intravitreal Agents for the Treatment of Endophthalmitis. |
Q43274477 | Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report. |
Q35808527 | Endogenous endophthalmitis secondary to erysipelas. |
Q36241012 | Endogenous endophthalmitis: diagnosis, management, and prognosis. |
Q89128310 | Endophthalmitis Caused by Corynebacterium Species: Clinical Features, Antibiotic Susceptibility, and Treatment Outcomes |
Q53701120 | Endophthalmitis caused by gram-positive bacteria resistant to vancomycin: Clinical settings, causative organisms, antimicrobial susceptibilities, and treatment outcomes. |
Q37715252 | Endophthalmitis patients seen in a tertiary eye care centre in Odisha: a clinico-microbiological analysis |
Q33774225 | Endophthalmitis: Pathogenesis, clinical presentation, management, and perspectives |
Q33768795 | Enzymatic treatment of specimens before DNA extraction directly influences molecular detection of infectious agents |
Q41431964 | Etiology and antibacterial susceptibility pattern of community-acquired bacterial ocular infections in a tertiary eye care hospital in south India |
Q34101326 | Evaluating retinal toxicity of intravitreal caspofungin in the mouse eye. |
Q34431991 | Evaluation of phenotypic and molecular methods for detection of oxacillin resistance in members of the Staphylococcus sciuri group |
Q35044450 | External ocular surface bacterial isolates and their antimicrobial susceptibility patterns among pre-operative cataract patients at Mulago National Hospital in Kampala, Uganda |
Q33825830 | Identification and characterization of clinical isolates of members of the Staphylococcus sciuri group |
Q92132942 | In Vitro Biofilm Formation and Antibiotic Susceptibility Patterns of Bacteria from Suspected External Eye Infected Patients Attending Ophthalmology Clinic, Southwest Ethiopia |
Q89902167 | In vitro Susceptibilities of Methicillin-Susceptible and Resistant Staphylococci to Traditional Antibiotics Compared to a Novel Fluoroquinolone |
Q43276147 | Intracameral moxifloxacin: a safe option for endophthalmitis prophylaxis? In vitro safety profile for intraocular application |
Q41838062 | Intravitreal clearance of moxifloxacin |
Q44749776 | Intravitreal injection of antibiotics in endophthalmitis |
Q90739011 | Is It Time to Abandon Subconjunctival Antibiotics following Pars Plana Vitrectomy? |
Q36458285 | Isolates and antibiotic resistance of culture-proven endophthalmitis cases presented to a referral center in Tehran |
Q38898294 | Isolates and antibiotic susceptibilities of endophthalmitis in postcataract surgery: a 12-year review of culture-proven cases |
Q33856298 | Isolation and molecular characterization of Staphylococcus sciuri in the hospital environment. |
Q37348431 | Isolation of Propionibacterium acnes among the microbiota of primary endodontic infections with and without intraoral communication. |
Q33836612 | Levofloxacin disposition over time in aqueous humor of patients undergoing cataract surgery |
Q40544717 | Methicillin resistance and biofilm production of Staphylococcus epidermidis isolates from infectious and normal flora conjunctiva |
Q33571514 | Microbial flora and resistance in ophthalmology: a review |
Q38385383 | Microbial profile and antibiotic susceptibility of culture-positive bacterial endophthalmitis. |
Q38878153 | Microbiological Isolates and Antibiotic Susceptibilities: A 10-Year Review of Culture-Proven Endophthalmitis Cases |
Q34208923 | Microbiological and molecular characterization of human clinical isolates of Staphylococcus cohnii, Staphylococcus hominis, and Staphylococcus sciuri. |
Q38229979 | Microbiology and visual outcomes of culture-positive bacterial endophthalmitis in Oxford, UK. |
Q36086333 | Modeling approach to characterize intraocular doripenem pharmacokinetics after intravenous administration to rabbits, with tentative extrapolation to humans |
Q38827899 | Modeling intraocular bacterial infections |
Q33691158 | Nasal Carriage of Methicillin-Resistant and Methicillin-Sensitive Strains of Staphylococcus sciuri in the Indonesian Population |
Q34621983 | Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis |
Q37543539 | Pediatric Infectious Endophthalmitis: A 271-case Retrospective Study at a Single Center in China |
Q34597632 | Pharmacokinetics and safety of intravitreal caspofungin |
Q36285596 | Positive bacterial culture in conjunctival sac before cataract surgery with night stay is related to diabetes mellitus |
Q37615338 | Postcataract endophthalmitis caused by Enterococcus faecalis |
Q38189793 | Postoperative Endophthalmitis following Cataract Surgery in Asia |
Q47135136 | Prevention and management of postoperative endophthalmitis: A case-based approach |
Q44560347 | Prophylaxis for postcataract endophthalmitis |
Q34489348 | Propionibacterium acnes and Staphylococcus epidermidis isolated from refractory endodontic lesions are opportunistic pathogens |
Q36396438 | Propionibacterium acnes. |
Q98784937 | RNA-Seq analysis of differentially expressed genes of Staphylococcus epidermidis isolated from postoperative endophthalmitis and the healthy conjunctiva |
Q64067412 | Recurrent Endophthalmitis |
Q49844534 | Release of Moxifloxacin From Corneal Collagen Shields |
Q92998125 | Risk of Endophthalmitis in Boston Type 1 Keratoprosthesis Combined with Vitrectomy and Silicone Oil Insertion |
Q41908007 | Severe bacterial endophthalmitis: towards improving clinical outcomes |
Q33646908 | Sustained release of antibiotic from poly(2-hydroxyethyl methacrylate) to prevent blinding infections after cataract surgery |
Q49581179 | Systemic Moxifloxacin in Streptococcus viridans Endophthalmitis. |
Q38196002 | The ecological importance of the Staphylococcus sciuri species group as a reservoir for resistance and virulence genes |
Q46533701 | The efficacy of intravitreal piperacillin/tazobactam in rabbits with experimental Staphylococcus epidermidis endophthalmitis: a comparison with vancomycin |
Q36315038 | The intraocular lens: challenges in the prevention and therapy of infectious endophthalmitis and posterior capsular opacification |
Q36866018 | Toward improving therapeutic regimens for Bacillus endophthalmitis |
Q33292907 | Treatment of two postoperative endophthalmitis cases due to Aspergillus flavus and Scopulariopsis spp. with local and systemic antifungal therapy |
Q31162142 | Types and drug susceptibility patterns of bacterial isolates from eye discharge samples at Gondar University Hospital, Northwest Ethiopia |
Q98892033 | Using the West Midlands CONCERT to characterise regional incidence of acute-onset post cataract surgery endophthalmitis |
Q83079746 | [Fluoroquinolones in ophthalmology: mechanisms of action and resistance] |
Q80809035 | [Primary vitrectomy with intraocular antibiotic application in postoperative endophthalmitis] |
Search more.